TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

VIZZ

ACECLIDINE HYDROCHLORIDE
Approved 2025-07-31
1
Indication
--
Phase 3 Trials
0
Years on Market

Details

Status
Prescription
First Approved
2025-07-31
Routes
OPHTHALMIC
Dosage Forms
SOLUTION/DROPS

Companies

Active Ingredient: ACECLIDINE HYDROCHLORIDE

VIZZ Approval History

Loading approval history...

What VIZZ Treats

1 indications

VIZZ is approved for 1 conditions since its original approval in 2025. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Presbyopia
Source: FDA Label
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

VIZZ FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

VIZZ is indicated for the treatment of presbyopia in adults. VIZZ is a cholinergic agonist indicated for the treatment of presbyopia in adults .

VIZZ Patents & Exclusivity

Latest Patent: Mar 2044
Exclusivity: Jul 2030

Patents (5 active)

US12414942 Expires Mar 15, 2044
US12128036 Expires Oct 8, 2039
US10052313 Expires Mar 24, 2034
US9844537 Expires Mar 24, 2034
US11179328 Expires Mar 24, 2034

Exclusivity

NCE Until Jul 2030
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.